Who owns Telix Pharmaceuticals Ltd?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TLX from SEC Form 13F filings across 61 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 61 institutions disclosed 3.1M shares of Telix Pharmaceuticals Ltd worth $36.2M — about 0.9% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
61
13F holders
$36.2M
value, 2026 filers
0.9%
of shares outstanding (3.1M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TLX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 561,206 | $6.5M | 0.0% | 0.2% | -0.6% |
| 2 | LAZARD ASSET MANAGEMENT LLC | 284,207 | $3.3M | 0.0% | 0.1% | -2.0% |
| 3 | PORTLAND INVESTMENT COUNSEL INC. | 266,200 | $3.1M | 0.9% | 0.1% | 0.0% |
| 4 | Private Advisor Group, LLC | 197,250 | $2.3M | 0.0% | 0.1% | +13.1% |
| 5 | MARSHALL WACE, LLPNEW | 189,188 | $2.2M | 0.0% | 0.1% | new |
| 6 | MORGAN STANLEY | 165,978 | $1.9M | 0.0% | 0% | +42.5% |
| 7 | Integrated Wealth Concepts LLC | 164,397 | $1.9M | 0.0% | 0% | 0.0% |
| 8 | Hennion & Walsh Asset Management, Inc.NEW | 150,138 | $1.7M | 0.0% | 0% | new |
| 9 | UBS Group AG | 134,698 | $1.6M | 0.0% | 0% | +317.0% |
| 10 | BLAIR WILLIAM & CO/ILNEW | 122,985 | $1.4M | 0.0% | 0% | new |
| 11 | Raiffeisen Bank International AG | 115,000 | $1.3M | 0.0% | 0% | -11.5% |
| 12 | Quadrature Capital LtdNEW | 102,425 | $1.2M | 0.0% | 0% | new |
| 13 | JPMORGAN CHASE & CO | 77,538 | $876,185 | 0.0% | 0% | +35.2% |
| 14 | XY Capital Ltd | 71,291 | $821,985 | 0.8% | 0% | +468.0% |
| 15 | XTX Topco Ltd | 68,776 | $792,987 | 0.0% | 0% | +164.5% |
| 16 | Vanguard Personalized Indexing Management, LLC | 58,989 | $680,143 | 0.0% | 0% | +77.4% |
| 17 | NLB Skladi, upravljanje premozenja, d.o.o.NEW | 58,000 | $668,740 | 0.0% | 0% | new |
| 18 | Mariner, LLC | 37,085 | $427,593 | 0.0% | 0% | -14.6% |
| 19 | Capricorn Fund Managers LtdNEW | 36,100 | $416,233 | 0.0% | 0% | new |
| 20 | GTS SECURITIES LLCNEW | 35,537 | $409,742 | 0.0% | 0% | new |
| 21 | JANE STREET GROUP, LLCNEW | 33,389 | $384,975 | 0.0% | 0% | new |
| 22 | IHT Wealth Management, LLC | 32,295 | $372,366 | 0.0% | 0% | +29.0% |
| 23 | HRT FINANCIAL LPNEW | 25,637 | $295,000 | 0.0% | 0% | new |
| 24 | Portolan Capital Management, LLC | 25,424 | $293,139 | 0.0% | 0% | -95.3% |
| 25 | BNP PARIBAS FINANCIAL MARKETS | 20,516 | $236,549 | 0.0% | 0% | +71.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.